A pilot study into bosentan (Tracleer®) as an immunomodulating agent in patients with Behçet's disease.

Added 466 days ago (24.08.2020)
Authors: Houwen TBV, Hagen PMV, Kappen JH, Kuijpers RWAM, Daele PLAV, Dik WAV, Dik WAV, Laar JAMV
PubMed id: 32828115
Read article